Variability in Durations of Therapy for Gram-Negative Bloodstream Infections and Factors Associated With Prolonged Durations
- PMID: 40476029
- PMCID: PMC12138504
- DOI: 10.1093/ofid/ofaf298
Variability in Durations of Therapy for Gram-Negative Bloodstream Infections and Factors Associated With Prolonged Durations
Abstract
Data on treatment durations for gram-negative bloodstream infections in clinical practice are limited. In this study of 4240 gram-negative bloodstream infection episodes during 2019 from 24 US hospitals, the median duration of therapy was 12 days (IQR, 9-15); 59% were treated for >10 days. There was marked variability in treatment durations across hospitals.
Keywords: antimicrobial stewardship; antimicrobial treatment; duration of therapy; gram-negative bacteremia; gram-negative bloodstream infection.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures

Similar articles
-
Interventions to improve antibiotic prescribing practices for hospital inpatients.Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4. Cochrane Database Syst Rev. 2017. PMID: 28178770 Free PMC article.
-
Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.Cochrane Database Syst Rev. 2016 Feb 22;2(2):CD008382. doi: 10.1002/14651858.CD008382.pub2. Cochrane Database Syst Rev. 2016. PMID: 26899263 Free PMC article.
-
Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.Cochrane Database Syst Rev. 2021 Oct 7;10(10):CD003295. doi: 10.1002/14651858.CD003295.pub4. Cochrane Database Syst Rev. 2021. PMID: 34617602 Free PMC article.
-
Experience in Ceftazidime-Avibactam for treatment of MDR BGN infection in Oncologic Children.Braz J Infect Dis. 2025 Mar-Apr;29(2):104515. doi: 10.1016/j.bjid.2025.104515. Epub 2025 Feb 21. Braz J Infect Dis. 2025. PMID: 39985933 Free PMC article.
-
Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis.Clin Microbiol Rev. 2016 Jan;29(1):59-103. doi: 10.1128/CMR.00053-14. Clin Microbiol Rev. 2016. PMID: 26598385 Free PMC article.
References
-
- Yahav D, Franceschini E, Koppel F, et al. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis 2018; 69:1091–8. - PubMed
-
- von Dach E, Albrich WC, Brunel A-S, et al. Effect of C-reactive protein–guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA 2020; 323:2160–9. - PMC - PubMed
-
- Molina J, Montero-Mateos E, Praena-Segovia J, et al. Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by enterobacterales: a randomized, controlled trial. Clin Microbiol Infect 2022; 28:550–7. - PubMed
-
- BALANCE Investigators; Daneman N, Rishu A, Pinto R, et al. Antibiotic treatment for 7 versus 14 days in patients with bloodstream infections. N Engl J Med 2024; 392:1065–78. - PubMed
LinkOut - more resources
Full Text Sources